Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy.
Oh Y, Kim S, Kim Y, Kim H, Jang D, Shin S, Lee SJ, Kim J, Lee SE, Oh J, Yang Y, Kim D, Jung HR, Kim S, Kim J, Min K, Cho B, Seo H, Han D, Park H, Cho SY.
Oh Y, et al. Among authors: han d.
Mol Cancer. 2024 Aug 2;23(1):155. doi: 10.1186/s12943-024-02068-x.
Mol Cancer. 2024.
PMID: 39095793
Free PMC article.